baber/WOPTO huggingface dataset:
Patent AU-749889-B2 (AU)
Title: Method and apparatus for producing a respiratory filter
Inventor: BECKER FRANK
IPC: B01D39/00
Filed: 2001-04-23
Granted: 2002-07-04
Abstract: Producing a protective respiration filter, involves mixing of adsorptive, absorptive, chemisorptive or catalytic materials, in particular, activated carbon, with one or more meltable polymers and heating of this mixture under pressure. The heating process takes place in a connector element of an individual respiration filter or a fan filter, or in a connector element of adapters of such filters, and results in an airtight joint being formed between the pressed filter material and its container. An Independent claim is also included for an apparatus for implementation of the proposed method.
Patent AU-616044-B2 (AU)
Title: Cleansing composition for topical disinfection
Inventor: KAHN MOHAMMED A
IPC: A61K8/43
Filed: 1989-08-18
Granted: 1991-10-17
Abstract: An antimicrobial cleansing composition, particularly useful as a surgical scrub, comprises     (a) about 2 to 6% of a chlorhexidine salt; (b) about 4 to 6% of a nonylphenoxypoly(ethyleneoxy)ethanol surfactant; (c) at least one additional ingredient which is a polyethyleneglycol ether of lanolin, a polyethyleneglycol diester of a first fatty acid, and/or an amide of a second fatty acid; and   (d) water and may contain other surfactants, thickeners, emollients, dyes, perfumes and the like.
Patent AU-668163-B2 (AU)
Title: Timed release of water soluble plant nutrients
Inventor: LUTHRA NARENDER PAL
IPC: C05G3/00
Filed: 1993-06-08
Granted: 1996-04-26
Abstract: Products for the variable controlled release of water soluble agents are disclosed. The products have a core of water soluble agent and a first and second coating. The first coating has a permeability such that the agent can be released at a controlled rate, while the second coating has a relatively low water vapor transmission rate. Variation in the coating thicknesses and coating conditions result in nutrient release profiles which can be tailored to specific plant requirements. After application of the product, release of the agent is negligible, but after a predetermined time, e.g. one month or more, substantial release of the agent from the coated product begins. The product is particularly suitable for delayed, controlled release fertilizers.
Patent AU-697876-B2 (AU)
Title: New erythromycin derivatives, their preparation process and their use as medicaments
Inventor: AGOURIDAS CONSTANTIN
IPC: A61P31/04
Filed: 1995-12-08
Granted: 1998-10-22
Abstract: Erythromycin derivs. of formula (I) and their acid addn. salts are new. In (I), Q is a gp. of formula (i); R and R1 are OH or 2-20C O-acyl; R2 is H or CH3; R3 is either (CH2)mR4, (CH2)n-C(A)=C(B)-(CH2)pR4 or -N-(CH2)qR4; m is 1-6; n, p and q are 0-6; A and B are H, halo or 1-8C alkyl, or A+B+C atoms to which they are bonded form a triple bond; and R4 is mono- or poly-heterocyclic radical (opt. substd.).
Patent AU-674681-B2 (AU)
Title: Ocular androgen therapy in Sjogren's syndrome
Inventor: SULLIVAN DAVID A
IPC: A61K31/565
Filed: 1993-04-21
Granted: 1997-01-09
Abstract: The topical application to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutic amount of an androgen or androgen analogue is disclosed as a method of relieving the chronic and acute manifestation of dry eye symptoms in Sj+E,uml o+EE gren's syndrome.
Patent AU-683190-B2 (AU)
Title: Method and apparatus for manufacturing glass bottles
Inventor: NAKAGAWA MANABU
IPC: C03B35/04
Filed: 1996-02-02
Granted: 1997-10-30
Abstract: The problem of unevenness of bottle temperatures at the entry of slow annealing furnace due to the variation of time periods necessary for respective bottles discharged from an IS bottle manufacturing machine to reach the annealing furnace has been solved by an equalization of said time periods. For this purpose, the bottle discharging order from the IS bottle manufacturing machine is controlled and use is made of two conveyors having different running speeds and/or direction of running. As a result, a precise temperature control in the Hot-End-Coating apparatus provided upstream from the annealing furnace can be carried out owing to the equalized temperatures of bottles entering into the annealing furnace. <IMAGE>
Patent AU-690400-B2 (AU)
Title: 2-(2-amino-3-methoxyphenyl)-4-OXO-4H-(1)benzopyran for treating proliferative disorders
Inventor: BRIDGES ALEXANDER JAMES
IPC: A61K31/352
Filed: 1995-11-27
Granted: 1998-04-23
Abstract: 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran inhibits MEK and, as such, is effective in treating cancer and other proliferative diseases such as psoriasis and restenosis.
Patent AU-761477-B2 (AU)
Title: Bioactive whey protein hydrolysate
Inventor: SCHLOTHAUER RALF-CHRISTIAN
IPC: A23J3/34
Filed: 1999-06-14
Granted: 2003-06-05
Abstract: The invention relates to a partial hydrolysate of when protein which contains bioactive peptides but does not have a bitter flavour. The hydrolysate is carried out using selective enzymes which produce the active peptides and is terminated at a degree of hydrolysis before substantial bitter flavours are created. There are also described novel peptides and a method of reducing systolic blood pressure through the administration of the peptides.
Patent AU-581241-B2 (AU)
Title: Vehicle for transporting refuse or the like
Inventor: KRAPP GERHARD
IPC: B65F/
Filed: 1985-06-19
Granted: 1989-02-16
Abstract: PCT No. PCT/EP85/00299 Sec. 371 Date Mar. 31, 1986 Sec. 102(e) Date Mar. 31, 1986 PCT Filed Jun. 19, 1985 PCT Pub. No. WO86/00602 PCT Pub. Date Jan. 30, 1986.Vehicle for transporting refuse or the like comprising a container (2) secured to the frame (1) of the vehicle and provided with a rear foldable wall, the container (2) being transversely separated with respect to the longitudinal axis of the vehicle into two parts, the front part (3) being secure to the frame (1) of the vehicle and the rear part (4) being connected to the frame (1) of the vehicle so as to tilt upwardly about a transversal axis (5) situated at the end of the vehicle; in the container (2) there is arranged a pusher plate (15) covering the inner cross-section of the container, connected to a pushing drive (16) and displaceably arranged from the end of the container situated on the driver side longitudinally at least up to the guiding area of the container (2).
Patent AU-584122-B2 (AU)
Title: Metered dose aerosol of nifedipin
Inventor: BURGHART WALTER
IPC: A61K31/44
Filed: 1985-08-23
Granted: 1989-05-18
Abstract: The pharmaceutical preparation contains nifedipine as active agent and is conditioned as an aerosol by using a propelling gas or a spray. When using propelling gases, the preparation contains preferably from 2 to 5 % by weight of nifedipine, 25 to 40% by weight of polyethylene-glycol, 40 to 25% by weight of ethanol and 30 to 40% by weight, preferably 35% by weight of the propulsion agent, whereas in case of a spray, the preparation appropriately contains 19 mg of nifedipine, 70 to 100 mg of polyethylene-glycol, particularly a mixture of polyethylene-glycol 600 and polyethylene-glycol 400 in a ratio from 5:4 to 4:5, 30 to 40 mg of ethanol, 5 to 20 mg of water and optionally 2 to 5 mg of saccharine and 1 to 3 mg of flavouring agent like peppermint oil.
Patent AU-763954-B2 (AU)
Title: Compositions and methods for cancer treatment by selectively inhibiting VEGF
Inventor: THORPE PHILIP E
IPC: A61K47/48
Filed: 2000-04-28
Granted: 2003-08-07
Abstract: Disclosed are antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention thus provides new antibody-based compositions, methods and combined protocols for treating cancer and other angiogenic diseases. Advantageous immunoconjugate and prodrug compositions and methods using the new VEGF-specific antibodies are also provided. <IMAGE>
Patent AU-635727-B2 (AU)
Title: Manufacturing method for a flexible container
IPC: B31B50/86
Filed: 1989-12-21
Granted: 1993-04-01
Abstract: PCT No. PCT/NO89/00134 Sec. 371 Date Jul. 11, 1991 Sec. 102(e) Date Jul. 11, 1991 PCT Filed Dec. 21, 1989 PCT Pub. No. WO90/06844 PCT Pub. Date Jun. 28, 1990.A flexible container for lifting transportation and storing of bulk material is manufactured from a hose-like blank, where one half-length portion of the hose-like blank is turned inside out and threaded onto or fitted over the other half-length portion form an inner sack and an outer sack having a common base or individual abases. The hose-like blank has at a mid-length thereof two or more longitudinal slots or openings separated by the same distance around the circumference of the hose-like blank. One half-length portion is rotated with regard to the other half-length portion around a central axis of the hose-like blank, such that the material of the areas between the slots after rotation forms two or more integrated lifting loops.
Patent AU-628527-B2 (AU)
Title: Virtual instruction cache refill algorithm
Inventor: FITE DAVID B
IPC: G06F9/30
Filed: 1990-04-27
Granted: 1992-09-17
Abstract: An instruction buffer for a digital computer controls the flow of instruction stream to an instruction decoder (32). As each instruction is consumed, a shifter (70) removes the consumed bytes and repositions the remaining bytes into the lowest order positioned. The byte positions left empty are filled by instruction stream bytes retrieved from one of a pair of prefetch buffers (64, 66) or from a virtual instruction cache (28). One prefetch buffer (66) is filled from the instrction cache (28) after being emptied, but prior to those particular bytes being requested to fill the instruction decoder (32). The two-level prefetching allows the relatively slow process of cache access to be performed during noncritical time.
Patent AU-668260-B2 (AU)
Title: Recording paper and ink-jet recording process making use of the same
Inventor: SAKAKI MAMORU
IPC: D21H21/28
Filed: 1994-01-25
Granted: 1996-04-26
Abstract: Disclosed herein is recording paper suitable for use in recording making use of a water-based recording liquid containing a dye which varies from water-soluble to water-insoluble according to the change of pH, wherein the recording paper is neutral or alkaline, and the surface pH of the paper is adjusted to a value not higher than the pH at which the dye turns water-insoluble.
Patent AU-616119-B2 (AU)
Title: Agricultural foam compositions comprising polysaccharide or synthetic polymer plus surfactant
Inventor: SPROTT DAVID J
IPC: A01N25/16
Filed: 1990-06-01
Granted: 1991-10-17
Abstract: The present invention is directed to agricultural chemicals dispersed in an aqueous foam composition wherein the foam composition comprises a polysaccharide or synthetic polymer, a surfactant and an aqueous medium. Also disclosed are processes for seed treatment.
Patent AU-680595-B2 (AU)
Title: Method and gauge for measuring the sculpture depth of a motor vehicle tyre
Inventor: BURGER JOACHIM
IPC: G01B11/22
Filed: 1996-05-24
Granted: 1997-07-31
Abstract: PCT No. PCT/EP96/02241 Sec. 371 Date Jan. 24, 1997 Sec. 102(e) Date Jan. 24, 1997 PCT Filed May 24, 1996 PCT Pub. No. WO96/37754 PCT Pub. Date Nov. 28, 1996For measuring the tread depth of the tyre of a motor vehicle by means of a measuring head containing a laser (67), the laser measuring head is positioned relative to the tyre of the motor vehicle in such a way, that a reference surface or plane adopts a well-defined position with respect to the tyre. The laser beam (66) of the laser (67) is directed through the reference surface (68) at an angle ( alpha ) to the bottom (64) of the tyre tread, whereby a light spot (78) is generated on this bottom (64) of the tyre tread. The position (e) of the light spot (78) is observed by an image resolving sensor (82). Therefrom, a measure (t) of the depth of the tyre tread is gained.
Patent AU-754245-B2 (AU)
Title: Embedded web phone module
Inventor: KIKINIS DAN
IPC: H04M11/00
Filed: 1999-09-02
Granted: 2002-11-07
Abstract: A system for enabling Data Network Telephony (DNT) communication through a WEB page includes a Web server hosting an interactive WEB page and having an Internet port, a link in the WEB page adapted for launching a DNT-capable telephone module, and a DNT-capable telephone module associated with the link. In this system, upon selection of the link by a person accessing the WEB page over the Internet using a computer platform, an instance of the IP telephone module is downloaded to computer platform, and an IP call is launched to an IP address pre-stored and associated with the link. The DNT network may be the Internet. In a preferred embodiment the system first investigates the computer platform for hardware and software characteristics, and attaches the determined characteristics to the instance of the IP telephone module to be downloaded. The downloaded module then self-launches and configures, and then launches the associated call. In some embodiments the module disappears after a single call, and thus serves as an instant enabler for IP telephony.
Patent AU-771681-B2 (AU)
Title: Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
Inventor: HILLEBRAND TIMO
IPC: C12N15/10
Filed: 1999-07-23
Granted: 2004-04-01
Abstract: The subject of the invention are formulations not containing chaotropic components for isolating nucleic acids with binding to a solid phase, in particular of DNA, from optional complex starting materials and quantities containing a lysis/binding buffer system which comprises at least one antichaotropic salt component, a solid phase and wash and elution buffers known as such. The lysis/binding buffer system may be an aqueous solution or a solid formulation in reaction vessels ready for use. All carriers used for isolation by means of chaotropic reagents, preferably glass fiber mats, glass membranes, silica carriers, ceramics, zeolites or materials showing negatively functionalised surfaces or chemically modified surfaces which may be converted to a negative charge potential may serve as a solid phase.Furthermore, the subject of the invention is a method for isolating nucleic acids, in particular DNA, from optional complex starting materials with using the formulations according to the invention which is characterized by the lysis of the starting material, binding of nucleic acids to a carrier, washing of the nucleic acids bound to the carrier and elution of nucleic acids.
Patent AU-708595-B2 (AU)
Title: Inhalation device and method
Inventor: SHEPHERD MICHAEL TREVOR
IPC: A61M15/00
Filed: 1996-06-28
Granted: 1999-08-05
Abstract: An inhalation device comprising a chamber having an inlet and an outlet; and an active substance reservoir, wherein the device further includes vacuum means for forming a vacuum in the chamber and valve means arranged to release the vacuum, so that the substance contained in the reservoir is dispersed in the chamber on release of the vacuum.
Patent AU-674414-B2 (AU)
Title: Method of separating glycosylated and non-glycosylated proteins
Inventor: PRICE ALBERT E
IPC: C07K1/18
Filed: 1994-05-04
Granted: 1996-12-19
Abstract: This invention relates to a method for separating glycosylated prolactin from non-glycosylated prolactin. The method comprises the following steps: 1) equilibrating the prolactin containing solution with an equilibrating solution containing at least one organic solvent; 2) adding the equilibrated prolactin solution onto a chromatographic column containing a packing for the ion-exchange affinity separation of glycosylated and non-glycosylated prolactin; 3) eluting the glycosylated prolactin from the chromatographic column with a sufficient quantity of a first eluting solution containing at least one organic solvent and with or without at least one salt, wherein the salt concentration and/or organic solvent concentration and/or pH are appropriate for the eluting of glycosylated prolactin being substantially free of non-glycosylated prolactin; and 4) eluting the non-glycosylated prolactin from the chromatographic column with a sufficient quantity of a first eluting solution containing at least one organic solvent and with or without at least one salt, wherein the salt concentration and/or organic solvent concentration and/or pH are appropriate for the eluting of non-glycosylated prolactin being substantially free of glycosylated prolactin.
Patent AU-544636-B2 (AU)
Title: Derivatives of aldohexoses
Inventor: HARTMANN ALBERT
IPC: C07H1/00
Filed: 1981-02-13
Granted: 1985-06-06
Abstract: Described are derivatives of pyranoses of the formula I, manufacturing processes and intermediates, and their use as medicaments.    <IMAGE>  (I)  The pyranose moiety in the compounds of the formula I is derived especially from D-glucose, but alternatively from D-galactose or D-mannose. Characteristic of the compounds of the formula I is the lower alkyl or phenyl-lower alkyl radical R8, which carries an oxycarbonyl, mercaptocarbonyl or aminocarbonyl group, which is bonded to an aliphatic, cycloaliphaticaliphatic, cycloaliphatic or aromatic hydrocarbon radical R0, each of which is optionally substituted and which may be interrupted by oxycarbonyl, mercaptocarbonyl and/or iminocarbonyl and which, like the remaining radicals of the formula I, is defined in patent claim 1.
Patent AU-740052-B2 (AU)
Title: Anti-fibrotic agent assay
Inventor: GEESIN JEFFREY C
IPC: A61K38/00
Filed: 1997-10-24
Granted: 2001-10-25
Abstract: A novel method has been developed for screening anti-scarring and anti-fibrotic agents. This method offers simplicity, it is reproducible and could be adopted to screen a large number of new potential anti-fibrotic agents. This method has characteristics in common with the BAEC/BASMC co-culture system, but is more sensitive and does not require screening a large number of clonal lines for developing an effective method. In this system, similarly to the co-culture system, activation of L-TGF- beta 1 occurs by several independent mechanisms which involve binding of the latent complex to M6P/IGF-II receptors, thrombospondin and/or tissue type II transglutaminase. But, in contrast to the co-culture system, this macrophage-dependent system does not appear to involve plasmin. Using this method, potential novel anti-fibrotic agents such as IGF-II (used separately or in combination with IGFBP-2 as a delivery vehicle), tissue type II transglutaminase inhibitors and anti-inflammatory agents (such as hydrocortisone) were identified. A potential novel mechanism of action for Mannose 6-Phosphate has been proposed which is based on downregulation of M6P/IGF-II receptor and TGF- beta 1 mRNAs.
Patent AU-595357-B2 (AU)
Title: Thermoforming flexible plastic foam shells
Inventor: MENARD MICHAEL J
IPC: B29C51/04
Filed: 1987-08-14
Granted: 1990-03-29
Abstract: An improved method and apparatus for rapidly forming plastic foam shells from a flexible foam sheet. The foam sheet (10a) is intermittently passed through a radiaent heating unit and is rapidly heated on both sides to 130-250 DEG F to soften the foam. The heated foam sheet is immediately passed through a forming die unit in which the foam sheet is deformed partly into the die cavity (23) by withdrawal of air from the cavity, and a die plug (25) descends and final forms a shell while rapidly cooling the foam shell to below its plastic deformation temperature. By this forming method and apparatus, ethylene-containing foam shells having a depth 10-25 times the foam sheet initial thickness are rapidly formed at 10-30 cycles/minute.
Patent AU-713280-B2 (AU)
Title: In vitro chondrogenic induction of human mesenchymal stem cells
Inventor: JOHNSTONE BRIAN
IPC: A61K35/30
Filed: 1996-11-15
Granted: 1999-11-25
Abstract: Disclosed are a composition of chemically defined components which support the in vitro chondrogenesis of mesenchymal progenitor cells, a method for in vitro chondrogenic induction of such progenitor cells and a method of forming human chondrocytes in vitro from such progenitor cells.
Patent AU-598584-B2 (AU)
Title: Benzhydryloxyethylpiperidine derivatives, process for their preparation and pharmaceutical compositions in which they are present
Inventor: BUZAS ANDRE
IPC: C07D211/34
Filed: 1987-09-07
Granted: 1990-06-28
Abstract: Derivatives corresponding to either of the formulae which follow: 
<IMAGE>
 in which:
 - R1, R2, R3 and R4, which are identical or different, denote a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an aryloxy group or the trifluoromethyl group,
 - R denotes hydrogen, a cation, an alkyl group, an aryl group or an arylalkyl group,
 - n is equal to 0 or 1, and their pharmaceutically acceptable salts. 
<??>Application: treatment of spasmodic states and of allergies.
Patent AU-681705-B2 (AU)
Title: Endosomolytically active particles
Inventor: COTTEN MATTHEW
IPC: C12N15/87
Filed: 1994-10-07
Granted: 1997-09-04
Abstract: PCT No. PCT/EP94/03313 Sec. 371 Date Apr. 12, 1996 Sec. 102(e) Date Apr. 12, 1996 PCT Filed Oct. 7, 1994 PCT Pub. No. WO95/10624 PCT Pub. Date Apr. 20, 1995Endosomolytically active virus-like particle which is made up of units of capsid proteins of viruses or virus-like particles, the capsid protein units having a membrane-active peptide sequence. The particles are suitable as components of compositions for transporting nucleic acids into higher eukaryotic cells by receptor-mediated endocytosis.
Patent AU-549640-B2 (AU)
Title: Tropyl benzoate derivatives
Inventor: FOZARD JOHN RICHARD
IPC: C07D451/12
Filed: 1982-06-10
Granted: 1986-02-06
Abstract: Migraine is treated with a tropyl benzoate derivative of the following general Formula 1:-wherein:-R, represents C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy; or halogen;R<sub>2</sub> represents hydrogen, C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy or halogen; andR<sub>3</sub> represents hydrogen, C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy, or halogen provided that R<sub>3</sub> is hydrogen when R<sub>2</sub> is hydrogen.Some of the tropyl benzoate derivatives of Formula I are novel compounds.
Patent DE-1814579-B2 (DE)
Title: Aluminium nitride coated crucibles
IPC: C04B41/50
Filed: 1968-12-13
Abstract: Crucibles for high temperature work, conventionally made by hot-pressing alumina, aluminium nitride, etc., may be made by coating quartz, hard carbon or graphite with a layer of aluminium nitride. The article to be coated is held at 1000-1100 degrees C and bathed in ammonia or ammonia diluted with nitrogen, mixed at that point with a stream of aluminium halide in a carrier gas such as nitrogen. The stream of halide, preferably chloride or bromide, is prepared by passing nitrogen over the halide at 150-180 degrees C. The coating of aluminium nitride used is 100-200 mu thick.
Patent DE-1920136-B2 (DE)
Title: Connection for two profile bars - has retainer flange on connection piece filling groove of one bar
IPC: E06B3/60
Filed: 1969-04-21
Abstract: Connection for the two profile bars on a gate or door panel frame consists of a connection piece which is essentially U shaped. The holder of the connection piece consists of a retainer flange which has a dove-tailed cross section and fills a groove on the first profile which has rear cut wallings. The retainer flange is located on the bar of the connection piece and the side pieces of the connection piece are pressed against the walls of the second profile bar. A flange protrudes sideways from the connecting piece and engages into a groove on the first profile bar.